EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Omitted staging PSMA PET/CT is associated with advance disease extent at time of PSA persistence: a single center retrospective analysis

Andrea Di Giorgio, Marco Rapa, Martina Di Franco, Caterina Maria Paola Sgro, Giambattista Siepe, Veronica Mollica, Lorenzo Bianchi, Matteo Droghetti, Paolo Castellucci, Riccardo Mei, Andrea Farolfi, Riccardo Schiavina und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (8) · 4895-4904

DOI: 10.1007/s00259-026-07799-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 10.03.2026. Verfasst von Andrea Di Giorgio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, Bologna, 40138, Italy. andrea.digiorgio2@studio.unibo.it. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Prostate-Specific Antigen, Oligopeptides. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alma Mater Studiorum - Università di Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsProstate-Specific AntigenOligopeptidesHumansMaleRetrospective StudiesNeoplasm StagingAgedMiddle AgedGallium IsotopesGallium RadioisotopesEdetic Acid

Stichwörter der Autor:innen

Intermediate RiskPSMA PET/CTPersistence DiseaseProstate CancerStaging

Substanzen

Prostate-Specific AntigenGallium IsotopesGallium Radioisotopesgallium 68 PSMA-11Edetic AcidOligopeptides

Autor:innen und Institutionen

  • Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, Bologna, 40138, Italy. andrea.digiorgio2@studio.unibo.it.
  • Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, Bologna, 40138, Italy.
  • Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, 40138, Italy.
  • Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy.
  • Nuclear Medicine, IRCCS, Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Förderung

  • Alma Mater Studiorum - Università di Bologna

Zitieren

APA

Di Giorgio, A., Rapa, M., Di Franco, M., Sgro, C. M. P., Siepe, G., Mollica, V., Bianchi, L., Droghetti, M., Castellucci, P., Mei, R., Farolfi, A., Schiavina, R., & Fanti, S. (2026). Omitted staging PSMA PET/CT is associated with advance disease extent at time of PSA persistence: a single center retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging, 53(8), 4895-4904. https://doi.org/10.1007/s00259-026-07799-1

Vancouver

Di Giorgio A, Rapa M, Di Franco M, Sgro CMP, Siepe G, Mollica V, et al. Omitted staging PSMA PET/CT is associated with advance disease extent at time of PSA persistence: a single center retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(8):4895-4904. doi:10.1007/s00259-026-07799-1

BibTeX
@article{DiGiorgio2026,
  author = {Di Giorgio, Andrea and Rapa, Marco and Di Franco, Martina and Sgro, Caterina Maria Paola and Siepe, Giambattista and Mollica, Veronica and Bianchi, Lorenzo and Droghetti, Matteo and Castellucci, Paolo and Mei, Riccardo and Farolfi, Andrea and Schiavina, Riccardo and Fanti, Stefano},
  title = {Omitted staging PSMA PET/CT is associated with advance disease extent at time of PSA persistence: a single center retrospective analysis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {8},
  pages = {4895--4904},
  doi = {10.1007/s00259-026-07799-1}
}
Kostenlos starten →